Vascular graft infections

Swiss Medical Weekly

Volumn 143, Issue , 2013, Pages

  Hasse, Barbara ^a   Husmann, Lars ^b   Zinkernagel, Annelies ^a   Weber, Rainer ^a   Lachat, Mario ^b   Mayer, Dieter ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

Author keywords

18Ffluorodeoxyglucose positron emission tomography; Computed tomographic angiography; Graft preservation; Negative pressure wound therapy; Prosthetic vascular graft infection

Indexed keywords

CEFUROXIME; METRONIDAZOLE; QUINOLONE; RIFAMPICIN; SULFAMETHOXAZOLE; TETRACYCLINE; TRIMETHOPRIM; ANTIINFECTIVE AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BLOODSTREAM INFECTION; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DEBRIDEMENT; DIABETES MELLITUS; DISEASE COURSE; GRAFT INFECTION; HEART FAILURE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; KIDNEY FAILURE; PATHOGENESIS; POLYMERASE CHAIN REACTION; POSITRON EMISSION TOMOGRAPHY; PROSTHETIC VASCULAR GRAFT INFECTION; RISK FACTOR; SKIN ULCER; STAPHYLOCOCCUS AUREUS; SURGICAL INFECTION; TREATMENT OUTCOME; VACUUM ASSISTED CLOSURE; WOUND INFECTION; BLOOD VESSEL GRAFT; BLOOD VESSEL PROSTHESIS; MICROBIOLOGY; REVIEW;

ANTI-BACTERIAL AGENTS; BLOOD VESSEL PROSTHESIS; DEBRIDEMENT; HUMANS; NEGATIVE-PRESSURE WOUND THERAPY; SURGICAL WOUND INFECTION; VASCULAR GRAFTING;

MLCS; MLOWN;

EID: 84877720599     PISSN: 14247860     EISSN: 14243997     Source Type: Journal    
DOI: 10.4414/smw.2013.13754     Document Type: Article

References (51)

1. Darouiche RO. Treatment of infections associated with surgical implants. N Engl J Med. 2004;350:1422-9. (Pubitemid 38419996)
2. Saleem BR, Meerwaldt R, Tielliu IF, Verhoeven EL, van den Dungen JJ, Zeebregts CJ. Conservative treatment of vascular prosthetic graft infection is associated with high mortality. Am J Surg. 2010;200(1):47-52
3. Calligaro KD, Veith FJ, Yuan JG, Gargiulo NJ, Dougherty MJ. Intra-ab-dominal aortic graft infection: complete or partial graft preservation in patients at very high risk. J Vasc Surg. 2003;38:1199-205. (Pubitemid 37517646)
4. Bandyk DF. Vascular surgical site infection: risk factors and preventive measures. Semin Vasc Surg. 2008;21:119-23.
5. Swain TW, 3rd, Calligaro KD, Dougherty MD. Management of infected aortic prosthetic grafts. Vasc Endovascular Surg. 2004;38:75-82. (Pubitemid 38140276)
6. Antonios VS, Noel AA, Steckelberg JM, Wilson WR, Mandrekar JN, Harmsen WS, et al. Prosthetic vascular graft infection: a risk factor analysis using a case-control study. J Infect. 2006;53:49-55. (Pubitemid 43960453)
7. Turtiainen J, Saimanen E, Partio T, Karkkainen J, Kiviniemi V, Makinen K, et al. Surgical wound infections after vascular surgery: prospective multicenter observational study. Scand J Surg. 2010;99:167-72.
8. Nagpal A, Sohail MR. Prosthetic vascular graft infections: a contemporary approach to diagnosis and management. Curr Infect Dis Rep. 2011;13:317-23.
9. Seeger JM. Management of patients with prosthetic vascular graft infection. Am Surg. 2000;66:166-77. (Pubitemid 30106301)
10. Stone PA, Back MR, Armstrong PA, Brumberg RS, Flaherty SK, Johnson BL, et al. Evolving microbiology and treatment of extracavitary prosthetic graft infections. Vasc Endovascular Surg. 2008;42:537-44.
11. Mayer D, Hasse B, Koelliker J, Enzler M, Veith FJ, Rancic Z, et al. Long-term results of vascular graft and artery preserving treatment with negative pressure wound therapy in Szilagyi grade III infections justify a paradigm shift. Ann Surg. 2011;254:754-9; discussion 760.
12. FitzGerald SF, Kelly C, Humphreys H. Diagnosis and treatment of prosthetic aortic graft infections: confusion and inconsistency in the absence of evidence or consensus. J Antimicrob Chemother. 2005;56:996-9. (Pubitemid 43009812)
13. Bergamini TM, Bandyk DF, Govostis D, Vetsch R, Towne JB. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J Vasc Surg. 1989;9:665-70. (Pubitemid 19149428)
14. Kanemitsu S, Shimono T, Nakamura A, Yamamoto K, Wada H, Shimpo H. Molecular diagnosis of nonaneurysmal infectious aortitis. J Vasc Surg. 2011;53:472-4.
15. Anagnostakos K, Mosser P. Bacteria identification on NPWT foams: clinical relevance or contamination? J Wound Care. 2012;21:333-4, 336-9.
16. Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1972;176:321-33.
17. Samson RH, Veith FJ, Janko GS, Gupta SK, Scher LA. A modified classification and approach to the management of infections involving peripheral arterial prosthetic grafts. J Vasc Surg. 1988;8:147-53.
18. Low RN, Wall SD, Jeffrey RB, Jr., Sollitto RA, Reilly LM, Tierney LM, Jr. Aortoenteric fistula and perigraft infection: evaluation with CT. Radiology. 1990;175:157-62. (Pubitemid 20108559)
19. Mark A, Moss AA, Lusby R, Kaiser JA. CT evaluation of complications of abdominal aortic surgery. Radiology. 1982;145:409-14. (Pubitemid 12002891)
20. Fiorani P, Speziale F, Rizzo L, De Santis F, Massimi GJ, Taurino M, et al. Detection of aortic graft infection with leukocytes labeled with technetium 99m-hexametazime. J Vasc Surg. 1993;17:87-95; discussion 95-86.
21. Stumpe KD, Dazzi H, Schaffner A, von Schulthess GK. Infection imaging using whole-body FDG-PET. Eur J Nucl Med. 2000;27:822-32. (Pubitemid 30456765)
22. von Schulthess GK, Meier N, Stumpe KD. Joint accumulations of FDG in whole body PET scans. Nuklearmedizin. 2001;40:193-7. (Pubitemid 34019435)
23. Fukuchi K, Ishida Y, Higashi M, Tsunekawa T, Ogino H, Minatoya K, et al. Detection of aortic graft infection by fluorodeoxyglucose positron emission tomography: comparison with computed tomographic findings. J Vasc Surg. 2005;42:919-25. (Pubitemid 41571959)
24. Keidar Z, Engel A, Hoffman A, Israel O, Nitecki S. Prosthetic vascular graft infection: the role of 18F-FDG PET/CT. J Nucl Med. 2007;48:1230-6. (Pubitemid 47242786)
25. Bruggink JL, Glaudemans AW, Saleem BR, Meerwaldt R, Alkefaji H, Prins TR, et al. Accuracy of FDG-PET-CT in the diagnostic work-up of vascular prosthetic graft infection. Eur J Vasc Endovasc Surg. 2010;40:348-54.
26. Stadler P, Bilohlavek O, Spacek M, Michalek P. Diagnosis of vascular prosthesis infection with FDG-PET/CT. J Vasc Surg. 2004;40:1246-7. (Pubitemid 40037298)
27. Spacek M, Belohlavek O, Votrubova J, Sebesta P, Stadler P. Diagnostics of "non-acute" vascular prosthesis infection using 18F-FDG PET/CT: our experience with 96 prostheses. Eur J Nucl Med Mol Imaging. 2009;36:850-8.
28. Coselli JS, Koksoy C, LeMaire SA. Management of thoracic aortic graft infections. Ann Thorac Surg. 1999;67:1990-3; discussion 1997-1998. (Pubitemid 29301398)
29. Roy D, Grove DI. Efficacy of long-term antibiotic suppressive therapy in proven or suspected infected abdominal aortic grafts. J Infect. 2000;40:184-204.
30. Baddour LM. Long-term suppressive antimicrobial therapy for intravas-cular device-related infections. Am J Med Sci. 2001;322:209-12. (Pubitemid 32973273)
31. Cherry KJ, Jr., Roland CF, Pairolero PC, Hallett JW, Jr., Meland NB, Naessens JM, et al. Infected femorodistal bypass: is graft removal mandatory? J Vasc Surg. 1992;15:295-303; discussion 303-295.
32. Gutowski P. Aortoiliac graft infection as a diagnostic and treatment problem. Ann Acad Med Stetin. 1998;Suppl 41:1-72.
33. Topel I, Audebert F, Betz T, Steinbauer MG. Microbial Spectrum and Primary Resistance to Rifampicin in Infectious Complications in Vascular Surgery: Limits to the Use of Rifampicin-Bonded Prosthetic Grafts. Angiology. 2010;61:423-6.
34. D'Addato M, Curti T, Freyrie A. Prophylaxis of graft infection with rifampicin-bonded Gelseal graft: 2-year follow-up of a prospective clinical trial. Italian Investigators Group. Cardiovasc Surg. 1996;4:200-4. (Pubitemid 26151968)
35. Braithwaite BD, Davies B, Heather BP, Earnshaw JJ. Early results of a randomized trial of rifampicin-bonded Dacron grafts for extra-anatomic vascular reconstruction. Joint Vascular Research Group. Br J Surg. 1998;85:1378-81. (Pubitemid 28468340)
36. Earnshaw JJ, Whitman B, Heather BP. Two-year results of a randomized controlled trial of rifampicin-bonded extra-anatomic dacron grafts. Br J Surg. 2000;87:758-9. (Pubitemid 30389277)
37. O'Connor S, Andrew P, Batt M, Becquemin JP. A systematic review and meta-analysis of treatments for aortic graft infection. J Vasc Surg. 2006;44:38-45.
38. Morykwas MJ, Argenta LC, Shelton-Brown EI, McGuirt W. Vacuum-assisted closure: a new method for wound control and treatment: animal studies and basic foundation. Ann Plast Surg. 1997;38:553-62. (Pubitemid 27251299)
39. Dosluoglu HH, Loghmanee C, Lall P, Cherr GS, Harris LM, Dryjski ML. Management of early (<30 day) vascular groin infections using vacuum-assisted closure alone without muscle flap coverage in a consecutive patient series. J Vasc Surg. 2010;51:1160-6
40. Dosluoglu HH, Schimpf DK, Schultz R, Cherr GS. Preservation of infected and exposed vascular grafts using vacuum assisted closure without muscle flap coverage. J Vasc Surg. 2005;42:989-92. (Pubitemid 41571969)
41. Nordmyr J, Svensson S, Bjorck M, Acosta S. Vacuum assisted wound closure in patients with lower extremity arterial disease. The experience from two tertiary referral-centres. Int Angiol. 2009;28:26-31.
42. Kragsterman B, Bjorck M, Wanhainen A. EndoVAC, a novel hybrid technique to treat infected vascular reconstructions with an endograft and vacuum-assisted wound closure. J Endovasc Ther. 2011;18:666-73.
43. BSAC-The British Society for Antimicrobial Chemotherapy. Treatment of hospital infections prosthetic vascular graft infections. ht-tp://www.bsac.org. uk (accessed 14 december 2011)
44. Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, et al. Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study. Clin Mi-crobiol Infect. 2012;18:352-6.
45. Szczot M, Meybeck A, Legout L, Pasquet A, Van Grunderbeeck N, Langlois J, et al. Vascular graft infections in the intensive care unit: clinical spectrum and prognostic factors. J Infect. 2011;62:204-11.
46. Pounds LL, Montes-Walters M, Mayhall CG, Falk PS, Sanderson E, Hunter GC, et al. A changing pattern of infection after major vascular reconstructions. Vasc Endovascular Surg. 2005;39:511-7. (Pubitemid 41790143)
47. Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc Endovascular Surg. 2005;39:327-34. (Pubitemid 41061699)
48. Kotsis T, Lioupis C. Use of vacuum assisted closure in vascular graft infection confined to the groin. Acta Chir Belg. 2007;107:37-44.
49. Pinocy J, Albes JM, Wicke C, Ruck P, Ziemer G. Treatment of peri-prosthetic soft tissue infection of the groin following vascular surgical procedures by means of a polyvinyl alcohol-vacuum sponge system. Wound Repair Regen. 2003;11:104-9. (Pubitemid 36514821)
50. Baddour LM, Wilson WR, Bayer AS, Fowler VG, Jr., Bolger AF, Levis-on ME, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation. 2005;111:e394-434.
51. Ohta T, Hosaka M, Ishibashi H, Sugimoto I, Takeuchi N, Kazui H, et al. Treatment for aortic graft infection. Surg Today. 2001;31:18-26. (Pubitemid 32200337)